CATEGORY: Issues

UC Health leaders advocate for Medicare, Medicaid funding

Washington visits part of broader coalitions of academic medical centers, public hospitals.

John Stobo

With more than $1 trillion in federal spending cuts looming, University of California Health leaders urged members of Congress and the Obama administration to protect Medicare and Medicaid funding.

UC Health Senior Vice President Dr. John Stobo and Chief Strategy Officer Santiago Muñoz recently visited Washington, D.C., as part of broader coalitions of academic medical centers and public hospitals. Their message: Significant cuts to Medicare or Medicaid would disproportionately hurt teaching hospitals such as UC Health’s five academic medical centers, decreasing patient access to complex care and worsening workforce shortages of health professionals.

The timing is critical. As part of the federal debt deal, Congress seeks to cut spending by an additional $1.2 trillion to $1.5 trillion. The 12-member bipartisan congressional “super committee” must produce its deficit-reduction proposal by Nov. 23, which could include cuts to health programs such as Medicare and Medicaid. Congress must vote on the proposal by Dec. 23, after which the president will either approve or veto it. If the congressional effort fails, $1.2 trillion in spending cuts will kick in automatically, including a 2 percent reduction in payments to Medicare providers starting in 2013.

UC Health’s concerns include potential reductions in Medicare payments for training physicians. Proposals have ranged from a cut of about 60 percent nationally ($60 billion over 10 years) to 10 percent ($9 billion over 10 years). This would hurt UC, which trains nearly half of California’s medical residents and receives about $200 million a year in Medicare graduate medical education payments.

“Our concern is the 6 percent of the 5,800 hospitals that are teaching hospitals may be disproportionally penalized,” Stobo said. “Teaching hospitals do 75 percent of all physician training, 40 percent of the charity care and 28 percent of inpatient Medicaid care. It doesn’t make any sense to cut back the support to educate physicians when we already have a shortage of physicians.”

Stobo joined a coalition of about 30 academic health centers, including Emory, Johns Hopkins and New York-Presbyterian, to make the case last week in Washington for protecting their missions.

“If you want to make cuts, make sure they are equally distributed,” Stobo said.

Santiago Muñoz

Muñoz visited Washington in mid-September with a delegation of public hospitals from California and across the nation.

“We’re not out just to protect ourselves,” Muñoz said. “We’re out to protect the programs that provide access to patients.”

UC Health is one of the largest providers of Medicare and Medicaid health care services in California, with a significant concentration of services often unavailable to patients in their local communities. Medicare and Medicaid payments account for approximately one-third of UC medical center revenue – more than $2 billion a year – providing vital support to UC’s mission to teach, research and provide care to all Californians.

UC and other California public hospitals are already focused on improving quality and efficiency through provisions in the Medicaid hospital financing waiver, Muñoz said. The agreement between the state and federal governments strengthens Medi-Cal, California’s Medicaid program, which serves 7 million Californians, including children, low-income families, the disabled and the elderly. For example, the waiver’s Delivery System Reform Incentive Program is a pay-for-performance initiative that creates incentives for public hospital systems to dramatically expand upon quality improvement projects.

“We have aggressive plans in place to improve how we are providing care,” Muñoz said.

UC Health leaders plan to keep delivering their message of protecting federal health funding. The worst-case scenario, Stobo said, is if the super committee reduces Medicare and Medicaid funding, but its total cuts are less than $1.2 trillion, triggering additional automatic cuts in payments to Medicare providers.

“It’s like ‘Rocky III’ when Clubber Lang is asked his prediction for the fight. What does he say? ‘Pain.’ This is going to be like that – enough pain for everybody,” Stobo said.

Related link:
How the debt deal could affect UC Health

CATEGORY: Issues, SpotlightComments Off

How the debt deal could affect UC Health

The impacts could be significant.

John D. Stobo

By John D. Stobo and Santiago Muñoz

The federal debt deal signed into law Tuesday (Aug. 2) could have significant impacts on UC Health’s five medical centers and 16 health professional schools. While all the details won’t be determined until the end of the year, here’s what we know.

In exchange for raising the national debt limit by at least $2.1 trillion, the federal government must cut spending by a similar amount in two steps. The first step immediately enacts 10-year discretionary spending caps designed to reduce the deficit by $917 billion. Medicare and Medicaid are exempt from cuts in this round, but health care workforce training programs and National Institutes of Health research funding will be reduced.

The next round of cuts will be $1.2 trillion to $1.5 trillion, depending on what a 12-member bipartisan congressional committee decides. This so-called “super committee” must produce its deficit-reduction proposal by Nov. 23. Everything will be on the table, including cuts to Medicare and Medicaid. Congress must vote on the proposal by Dec. 23, after which the president will either approve or veto it. But if the congressional effort fails, $1.2 trillion in spending cuts will automatically kick in. These include a 2 percent reduction in payments to Medicare providers starting in 2013.

Santiago Muñoz

That 2 percent Medicare cut could exceed $130 billion over 10 years. And depending on how the cuts are distributed, they could fall disproportionately on teaching hospitals such as UC medical centers.

UC Health is one of the largest providers of Medicare and Medicaid health care services in California, with a significant concentration of services often unavailable to patients in their local communities. UC Health relies heavily on Medicare and Medicaid payments to support its mission to teach, research and provide care to all Californians. This money accounts for over a third of UC medical center revenue – more than $2 billion a year.

Medicare funding for training physicians has been a key focus for discussions on how to reduce federal spending. One proposal called for a $60 billion cut over 10 years in Medicare support for graduate medical education. For UC, which trains nearly half of California’s medical residents, that cut translates to some $900 million over 10 years. UC would be forced to eliminate at least 600 medical resident positions, which would mean 420 fewer doctors entering the California health care workforce each year.

Moreover, the effects would ripple through the economy and undermine teaching hospitals’ efforts to provide vital services such as burn, cancer and trauma care.

UC Health recognizes that federal spending cuts are coming and has embraced the challenge of making difficult budget decisions while maintaining the highest standards of patient care. Each year we absorb significant underpayments by Medicare and Medicaid to help ensure health care access for California’s medically vulnerable. We have championed the federal government’s call for more accountability and improved clinical outcomes – notwithstanding the underfunding or the hundreds of millions of dollars we will not be paid unless we demonstrate increased value. Also, we have invested heavily in unearthing and spreading cost-saving innovations throughout our health system. Our new Center for Health Quality and Innovation holds enormous promise to attain these goals.

UC Health will continue to assess the situation and keep you informed. Californians have much at stake during this dialogue, including our health care infrastructure, which at its core includes UC Health.

John D. Stobo, M.D., is senior vice president for UC Health Sciences and Services. Santiago Muñoz is associate vice president – chief strategy officer for UC Health Sciences and Services.

CATEGORY: Issues, SpotlightComments Off

Innovation center issues white paper

Mission, goals, partnerships and possible next steps are outlined.

Terry Leach, executive director, UC Center for Health Quality and Innovation

The University of California’s Center for Health Quality and Innovation launched in October. A newly issued white paper outlines the center’s mission, goals, partnerships and possible next steps. The white paper, written by center Executive Director Terry Leach, also gives context on why UC Health started the center. The center, which recently awarded its first round of grants, seeks to promote and advance innovations in clinical care that will improve patient outcomes and quality of care within the UC system and beyond.

>>Download the white paper

CATEGORY: Issues, NewsComments Off

Training physicians: GME at UC

Medicare support provides vital funding to train doctors and maintain patient access.


California needs more doctors. The state already faces a physician shortage and it will grow to as many as 17,000 doctors by 2015. The demand for doctors will only increase as the population ages and more people become insured through federal health reform.

The physician work force is aging. California has the largest percentage of physicians (30 percent) who are over age 60 and ready to retire in the next few years.

The University of California plays a critical role in training physicians. UC trains more than 3,100 medical students, nearly half of the state’s total. UC also trains more than 4,400 medical residents and fellows, nearly half of the state’s total.

A cut in federal funding for training physicians would have a devastating impact on the health of California and the nation. The president’s National Commission on Fiscal Responsibility and Reform (“deficit commission”) proposed a $60 billion cut over 10 years in Medicare support for graduate medical education.

If Congress supports the deficit commission’s GME recommendations, UC would lose an estimated $900 million over 10 years. This action would threaten patient access to care by shrinking UC’s physicians training programs and endangering access to critical services such as trauma or cancer care that many patients may someday need.

Read more:
Download brochure GME at UC
Download printer-friendly version

CATEGORY: Issues, NewsComments Off

Allied Health Workforce survey released

UCSF researchers help analyze data for the California Hospital Association report.


uch_cha_criticalrolesThe California Hospital Association in collaboration with its Healthcare Workforce Coalition, whose members include UC San Francisco representatives, has released results of its Allied Health Workforce Survey. The survey results highlights key findings regarding the impacts of the economy on the demand for allied health professionals and identifies hospital workforce needs in the next few years.

View the report (PDF)

CATEGORY: Issues, NewsComments Off

Medi-Cal hospital provider fee

Read a summary of AB 1383 and AB 1653′s implications for UC medical centers.


As a major priority for and supported by UC Health Sciences and Services and the UC medical centers, AB 1383 and AB 1653 are designed to provide much needed Medi-Cal rate increases to California hospitals and ensure access to hospital care for low-income Californians.

Health Sciences and Services has prepared a summary on the recently enacted statutes’ implications for UC medical centers.

Read the summary (PDF)

CATEGORY: Issues, NewsComments Off

California 1st state to create health benefit exchange

California Health Benefit Exchange will help California consumers and small businesses shop for and buy competitive health insurance starting in 2014.

Gov. Arnold Schwarzenegger

Gov. Arnold Schwarzenegger

Gov. Arnold Schwarzenegger signed two bills that will make California the first state to establish a health insurance exchange under the federal health reform law. The governor also unveiled a new state website to help Californians understand changes under federal health reform.

View governor’s press release

See media coverage: San Francisco Chronicle, The Sacramento Bee, Los Angeles Times, The Associated Press, Sacramento Business JournalCalifornia Healthline


CATEGORY: Issues, NewsComments Off

UC statement on stem cell lawsuit ruling

Statement by the University of California regarding the U.S. Federal Court of Appeals decision to issue a stay pending appeal in the case of Sherley v. Sebelius.


uch_uci_stemcell_andersonThe University of California applauds the U.S. Court of Appeals order issued today (Sept. 28) granting a stay of a lower court’s preliminary injunction in Sherley v. Sebelius pending the Justice Department’s appeal. We look forward to continuing our participation in the appeal as amicus curiae.

Human embryonic stem cell research holds great possibilities for advancing knowledge of fundamental cellular biology. Today’s decision by the court allows UC researchers — and researchers across the nation — to continue to pursue groundbreaking, ethical human embryonic stem cell research which holds tremendous potential for new cures and therapies for an array of life-threatening diseases affecting millions of Americans.

Background:
On Aug. 23, 2010, in the case of Sherley v. Sebelius, a federal trial court judge in Washington, D.C., issued a preliminary injunction prohibiting federal funding of research involving human embryonic stem cells (hESC). On Sept. 9, that injunction was temporarily suspended by a federal appellate court while it decides whether the injunction should be reinstated for the several months it likely will take the appeals court to review the case on the merits. On Sept. 20, the University of California filed a motion with the U.S. Federal Court of Appeals for the District of Columbia Circuit seeking to intervene in the case in order to assure the harm caused by the judicially imposed federal funding ban to the university and its researchers is fully considered. On Sept. 28, the U.S. Federal Court of Appeals issued a stay pending appeal of the injunction that was first issued on Aug. 23 in the case of Sherley v. Sebelius.

Related links:
University of California’s motion to intervene in Sherley v. Sebelius

Steven Beckwith declaration in support of regents’ motion

Arnold Kriegstein declaration in support of regents’ motion

UC statement Sept 27 regarding the U.S. Federal Court of Appeals decision to allow UC to participate as amicus curiae in the case of Sherley v. Sebelius

UC statement Sept 23 on stem cell lawsuit filings

UC statement Sept. 20 on seeking to intervene in stem cell lawsuit

UC San Francisco news release

NIH stem cell information

CATEGORY: Issues, NewsComments Off

UC statement on stem cell lawsuit decision

Statement by the University of California regarding the U.S. Federal Court of Appeals decision to allow UC to participate as amicus curiae in the case of Sherley v. Sebelius.


uch_uci_stemcell_andersonThe University of California welcomes the U.S. Court of Appeals’ recognition of our interest in the stem cell litigation as reflected in its order issued today (Sept. 27) that the university be permitted to participate in this important case as amicus curiae.

The university submitted papers to the court last week to directly weigh in on the significant harm to research institutions engaged in human embryonic stem cell research that will result from a suspension or termination of access to federal funds imposed by a lower court’s preliminary injunction. The university strongly believes that the scientific community should be permitted to move forward with this critical research.

Today’s action by the Court of Appeals allows UC to highlight the harm that the injunction, if allowed to stand, will cause to the ethical pursuit of human embryonic stem cell research, as well as the impact on the potential for new cures and therapies for an array of life-threatening diseases that holds great hope to millions of patients and their families.

The university will determine next steps in light of today’s proceedings and decision, as well as the Court of Appeals’ anticipated decision on the Justice Department’s motion to stay the preliminary injunction throughout the appeals process.

Background:
On Aug. 23, 2010, in the case of Sherley v. Sebelius, a federal trial court judge in Washington, D.C., issued a preliminary injunction prohibiting federal funding of research involving human embryonic stem cells (hESC). On Sept. 9, that injunction was temporarily suspended by a federal appellate court while it decides whether the injunction should be re-instated for the several months it likely will take the appeals court to review the case on the merits. On Sept. 20, the University of California filed a motion with the U.S. Federal Court of Appeals for the District of Columbia Circuit seeking to intervene in the case in order to assure the harm caused by the judicially imposed federal funding ban to the university and its researchers is fully considered.

Related links:
University of California’s motion to intervene in Sherley v. Sebelius

Steven Beckwith declaration in support of regents’ motion

Arnold Kriegstein declaration in support of regents’ motion

UC statement Sept. 28 on stem cell lawsuit ruling

UC statement Sept 23 on stem cell lawsuit filings

UC statement Sept. 20 on seeking to intervene in stem cell lawsuit

UC San Francisco Sept. 24 news release

UC San Francisco Sept. 20 news release

NIH stem cell information

CATEGORY: Issues, NewsComments Off

UC statement on stem cell lawsuit filings

Statement regarding filings by the U.S. Department of Justice and attorneys for appellees in response to UC’s motion with the U.S. Federal Court of Appeals to intervene in Sherley v. Sebelius.


uch_uci_stemcell_andersonThe University of California is pleased that, in its filing, the U.S. Department of Justice recognizes the direct and irreparable harm the injunction has caused and will continue to cause to the university and its researchers, as well as those for whom the promise of embryonic stem cell research holds tremendous hope. UC is pleased that the Department of Justice urges the court “to fully consider the university’s submissions in deciding this appeal.”

The University of California remains optimistic that the court will recognize our significant interests in the litigation, and looks forward to the court’s ruling.

As we have stated in the past, human embryonic stem cell research is a powerful tool for gaining better knowledge of fundamental cellular biology and holds the potential for new cures and therapies for an array of life-threatening diseases affecting millions of Americans. Understanding and ultimately realizing the potential of stem cells through the advancement of ethical scientific research is a priority for the University of California and our world-class research enterprise. The University of California believes it is imperative that the scientific community be permitted to move forward with embryonic stem cell research that provides hope to millions of patients and their families.

Background:
On Aug. 23, 2010, in the case of Sherley v. Sebelius, a federal trial court judge in Washington, D.C., issued a preliminary injunction prohibiting federal funding of research involving human embryonic stem cells (hESC). On Sept. 9, that injunction was temporarily suspended by a federal appellate court while it decides whether the injunction should be reinstated for the several months it likely will take the appeals court to review the case on the merits. On Sept. 20, the University of California filed a motion with the U.S. Federal Court of Appeals for the District of Columbia Circuit seeking to intervene in the case in order to assure the harm caused by the judicially imposed federal funding ban to the university and its researchers is fully considered. A decision from the court on UC’s motion is expected in the near future.

Related links:
University of California’s motion to intervene in Sherley v. Sebelius

Steven Beckwith declaration in support of regents’ motion

Arnold Kriegstein declaration in support of regents’ motion

UC statement Sept. 28 on stem cell lawsuit ruling

UC statement Sept. 27 on stem cell lawsuit decision

UC statement Sept. 20 on seeking to intervene in stem cell lawsuit

UC San Francisco Sept. 24 news release

UC San Francisco Sept. 20 news release

NIH stem cell information

CATEGORY: Issues, NewsComments Off

UC seeks to intervene in stem cell lawsuit

Statement from the University of California regarding the filing of a motion with the U.S Federal Court of Appeals to intervene in Sherley v. Sebelius.

uch_uci_stemcell_andersonHuman embryonic stem cell research is a powerful tool for gaining better knowledge of fundamental cellular biology and holds the potential for new cures and therapies for an array of life-threatening diseases affecting millions of Americans. Understanding and ultimately realizing the potential of stem cells through the advancement of ethical scientific research is a priority for the University of California and our world-class research enterprise.

The recent U.S. District Court preliminary injunction blocking federally funded human embryonic stem cell (hESC) research threatens ongoing potential life-saving research and undermines the time-honored system of peer-reviewed science.

The University of California is seeking to intervene in the case of Sherley v. Sebelius. The university takes this step in order to directly weigh in with the court regarding the harm to research institutions engaged in this critical research that will result from a suspension or termination of access to federal funds.

The University of California is the first research institution in the nation to formally seek to intervene in the pending lawsuit.

The University of California believes it is imperative that the scientific community be permitted to move forward with embryonic stem cell research that provides hope to millions of patients and their families.

UC is a global leader in ethical and scientific stem cell research. Following National Institutes of Health and federal guidelines, all 10 UC campuses are actively involved in stem cell research. The university has dedicated substantial effort to human embryonic stem cell research reflecting the strong consensus in the relevant scientific communities, in the state, and among university leaders that hESCs are a powerful research tool that can be used and are being used to better understand fundamental cellular biology and, eventually, to improve the health of our citizens.

Related links:
Regents’ motion to intervene in Sherley v. Sebelius

Steven Beckwith declaration in support of regents’ motion

Arnold Kriegstein declaration in support of regents’ motion

UC statement Sept. 28 on stem cell lawsuit ruling

UC statement Sept. 27 on stem cell lawsuit decision

UC statement Sept. 23 on stem cell lawsuit filings

UC San Francisco Sept. 24 news release

UC San Francisco Sept. 20 news release

NIH stem cell information

CATEGORY: Issues, NewsComments Off

Op-ed: Access to care

uch_stobo_jancolumnstoryDr. John D. Stobo is the University of California’s senior vice president for health sciences and services. This op-ed ran originally on Aug. 26 in California Healthline’s Think Tank.

Health reform is a historic opportunity. It will increase the number of insured people and provide a platform to transform the delivery of health care. Nowhere will this be noticed more than in California, where the focus should be on ensuring access to quality medical care.

The University of California is addressing the need for more family physicians — particularly doctors who treat Medi-Cal patients — on three fronts: expanding medical education, making innovations in health care delivery and advancing its medical safety net role.

Expanding medical education

UC Health trains three of every five medical students in California. UC has increased medical student enrollment for the first time in three decades, thanks to its Program in Medical Education — known as PRIME —  aimed at training physician-leaders committed to helping California’s underserved communities. PRIME enrollment is expected to grow from nearly 200 students last year to 300 students next year.

UC is slated to open a sixth medical school in 2012 at UC Riverside. UC Merced, which starts a PRIME program next year, is developing plans that could lead to a medical school. Also, UC Davis’ nursing school welcomes its inaugural class this fall. These are chances to train more health professionals where they are needed most.

Health care innovations

Increasing medical school enrollment is only part of the solution. To close the gap, medical school graduates would need to increase by more than two-thirds by 2015.

UC is using technology and improving care coordination to deliver health services more effectively and efficiently. The just-launched California Telehealth Network is a UC-led partnership that uses technology to expand access to care to all corners of the state. UCLA’s Pediatric Medical Home Program serves more than 90 children with special health care needs, a team approach to high-quality, cost-effective care. UC San Diego’s IMPACT-ED program, which will expand under a $15 million federal grant, uses an Internet-based referral system that allows emergency departments to schedule follow-up clinic appointments, thus improving care and reducing return ED visits. Health reform will encourage more such innovations that improve health care delivery.

Medical safety net role

Finally, the safety net must be stabilized. This is a priority for UC, where nearly one-fourth of patients are covered by Medi-Cal — a figure expected to increase with health reform.

Renewing the Medi-Cal waiver, set to expire at the end of August, is crucial to stabilizing Medi-Cal funding for safety net hospitals such as UC medical centers.

Read more

CATEGORY: Feature, Issues, NewsComments Off